Equities
  • Price (EUR)0.6556
  • Today's Change0.000 / -0.06%
  • Shares traded0.00
  • 1 Year change-5.10%
  • Beta2.4894
Data delayed at least 15 minutes, as of Feb 16 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Alibaba Health Information Technology Ltd grew revenues 13.22% from 27.03bn to 30.60bn while net income improved 62.14% from 883.48m to 1.43bn.
Gross margin24.48%
Net profit margin5.84%
Operating margin6.75%
Return on assets8.86%
Return on equity11.75%
Return on investment11.64%
More ▼

Cash flow in CNYView more

In 2025, cash reserves at Alibaba Health Information Technology Ltd fell by 1.27bn. However, the company earned 1.40bn from its operations for a Cash Flow Margin of 4.56%. In addition the company used 2.60bn on investing activities and also paid 72.52m in financing cash flows.
Cash flow per share0.1388
Price/Cash flow per share44.41
Book value per share1.23
Tangible book value per share1.16
More ▼

Balance sheet in CNYView more

Alibaba Health Information Technology Ltd uses little debt in its capital structure as supported by a debt to capital ratio of 0.43%.
Current ratio2.71
Quick ratio2.34
Total debt/total equity0.0043
Total debt/total capital0.0043
More ▼

Growth rates in CNY

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
53.45
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.